Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Cited by (1,005)

Items 201–300 of 1,005

1. Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation
   Jeff S. Healey, David J. Gladstone, Balakumar Swaminathan, Jens Eckstein, Hardi Mundl, Andrew E. Epstein, Karl Georg Hæusler, Robert Mikulík, Scott Eric Kasner, Danilo Toni et al. · 2019 · JAMA Neurology
2. Restarting Anticoagulant Therapy After Intracranial Hemorrhage
   Santosh B. Murthy, Ajay Kumar Gupta, Alexander Eliot Merkler, Babak Benjamin Navi, Pitchaiah Mandava, Costantino Iadecola, Kevin Navin Sheth, Daniel F. Hanley, Wendy Ziai, Hooman Kamel · 2017 · Stroke
3. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
   Renato D. Lópes, Sana M. Al‐Khatib, Lars C. Wallentin, Hongqiu Yang, Jack Ansell, Maria Cecilia Bahit, Raffaele De Caterina, Paul Dorian, J. Donald Easton, Çetin Erol et al. · 2012 · The Lancet
4. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia
   Richard L. Page, José A. Joglar, Mary A. Caldwell, Hugh G Calkins, JAMIE BETH CONTI, Barbara J. Deal, N.A. Mark Estes, Michael E. Field, Zachary D. Goldberger, Stephen C. Hammill et al. · 2015 · Heart Rhythm
5. Warfarin in atrial fibrillation patients with moderate chronic kidney disease
   Hart, Robert G., Pearce, Lesly A., Asinger, Richard W., Herzog, Charles A. · 2011 · Clinical Journal of the American Society of Nephrology
6. Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting
   John W. Eikelboom, Peter B. Berger, David R. Holmes, Deepak L. Bhatt, Richard Clinton Becker, Dominick Angiolill, David P. Faxon, David J. Moliterno · 2011 · Thrombosis and Haemostasis
7. Association of antithrombotic drug use with subdural hematoma risk
   Gaist, David, García Rodríguez, Luis Alberto, Hellfritzsch, Maja, Poulsen, Frantz Rom, Halle, Bo, Hallas, Jesper, Pottegård, Anton · 2017 · JAMA
8. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective
   Anuraag Kansal, Stuart J. Connolly, Siyang Peng, John E. Linnehan, Carole Bradley-Kennedy, Jonathan Plumb, Sonja V. Sorensen · 2011 · Thrombosis and Haemostasis
9. Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study
   Minjae Yoon, Pil‐Sung Yang, Eunsun Jang, Hee Tae Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Jung‐Hoon Sung, Hui‐Nam Pak, Moon‐Hyoung Lee et al. · 2019 · Thrombosis and Haemostasis
10. Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban
    Inna Y. Gong, Richard B. Kim · 2013 · Canadian Journal of Cardiology
11. Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
    Sean D. Pokorney, Jonathan Paul Piccini, Susanna R. Stevens, Manesh R. Patel, Karen S. Pieper, Jonathan L. Halperin, GÜNTER E. BREITHARDT, Daniel E. Singer, Graeme J. Hankey, Werner Hacke et al. · 2016 · Journal of the American Heart Association
12. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis
    Jonathan A C Sterne, Pritesh N. Bodalia, Peter A. Bryden, Philippa A. Davies, José A López-López, George N. Okoli, Howard H. Z. Thom, Deborah M Caldwell, Sofia Dias, Diane Eaton et al. · 2017 · Health Technology Assessment
13. Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension
    Manolis, Athanasios J., Rosei, Enrico Agabiti, Coca, Antonio, Cifkova, Renata, Erdine, Serap E., Kjeldsen, Sverre, Lip, Gregory Y.H., Narkiewicz, Krzysztof, Parati, Gianfranco, Redon, Josep et al. · 2012 · Journal of Hypertension
14. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
    Rustam Al‐Shahi Salman, MS Dennis, PAG Sandercock, Cathie L. M. Sudlow, Joanna Marguerite Wardlaw, William N. Whiteley, Gordon D. Murray, Jacqueline Stephen, David Ernest Newby, Nikola Sprigg et al. · 2019 · The Lancet
15. The State of the Art
    Daniel P. Morin, Michael L. Bernard, Christopher A. Madias, Paul A. Rogers, Sudarone Thihalolipavan, N.A. Mark Estes · 2016 · Mayo Clinic Proceedings
16. Journal of Pharmaceutical and Biomedical Sciences
    2016 · Journal of Pharmaceutical and Biomedical Sciences
17. Rate control in atrial fibrillation
    Isabelle C. Van Gelder, Michiel Rienstra, Harry J.G.M. Crijns, Brian Olshansky · 2016 · The Lancet
18. Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy
    Vanessa Roldán, Francisco R. Marín, Hermógenes Fernández, Sergio Manzano‐Fernández, Pilar Gallego, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip · 2012 · CHEST Journal
19. Risk of Falls and Major Bleeds in Patients on Oral Anticoagulation Therapy
    Jacques D. Donzé, Carole Clair, Balthasar L. Hug, Nicolas Rodondi, Gérard Waeber, Jacques Cornuz, Drahomir Aujesky · 2012 · The American Journal of Medicine
20. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
    Chern‐En Chiang, Ken Okumura, Shu Zhang, Tze‐Fan Chao, Chung‐Wah Siu, Toon Wei Lim, Anil Saxena, Yoshihide Takahashi, Wee Siong Teo · 2017 · Journal of Arrhythmia
21. The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation
    Vanessa Roldán, Francisco R. Marín, Sergio Manzano‐Fernández, Pilar Gallego, Juan Antonio Vilchez, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip · 2013 · Journal of the American College of Cardiology
22. Direct oral anticoagulants: evidence and unresolved issues
    Noel Chan, Magdalena Sobieraj‐Teague, John W. Eikelboom · 2020 · The Lancet
23. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
    Gallego, Pilar, Roldan, Vanessa, Marín, Francisco, Romera, Marta, Valdés, Mariano, Vicente, Vicente, Lip, Gregory Y. H. · 2013 · Thrombosis and Haemostasis
24. Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway
    Marco Proietti, Giulio Francesco Romiti, Brian Olshansky, Deirdre A. Lane, Gregory Y.H. Lip · 2018 · The American Journal of Medicine
25. Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery
    Daniel J. Friedman, Jonathan Paul Piccini, Tongrong Wang, Jiayin Zheng, S. Chris Malaisrie, David R. Holmes, Rakesh M. Suri, Michael J. Mack, Vinay Badhwar, Jeffrey Phillip Jacobs et al. · 2018 · JAMA
26. Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
    François Laliberté, Michel Cloutier, Winnie W. Nelson, Craig Ian Coleman, Dominic Pilon, William H. Olson, C.V. Damaraju, Jeffrey R Schein, Patrick Lefèbvre · 2014 · Current Medical Research and Opinion
27. Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
    Margaret C. Fang, Alan S. Go, Yuchiao Chang, Leila H. Borowsky, Niela K. Pomernacki, Natalia V. Udaltsova, Daniel E. Singer · 2010 · Circulation Cardiovascular Quality and Outcomes
28. Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
    Antonio Gómez‐Outes, Ana Isabel Terleira‐Fernández, Gonzalo Calvo, Ma Luisa Suárez‐Gea, Emilio Vargas · 2013 · Thrombosis
29. Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
    Rikke Sørensen, Gunnar Gislason, Christian Tobias Torp-Pedersen, Jonas Bjerring Olesen, Emil Loldrup Fosbøl, Morten Winther Hvidtfeldt, Deniz Karasoy, Morten Lamberts, Mette Gitz Charlot, Lars Køber et al. · 2013 · BMJ Open
30. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy
    Michiel Coppens, John W. Eikelboom, Robert G. Hart, Salim Yusuf, Gregory Y.H. Lip, Paul Dorian, Olga Shestakovska, Stuart J. Connolly · 2012 · European Heart Journal
31. Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke
    Brian H Buck, Michael D. Hill, F. Russell Quinn, Kenneth Butcher, Bijoy K. Menon, Sajad S. Gulamhusein, Muzaffar M. Siddiqui, Shelagh B. Coutts, Thomas Jeerakathil, Eric Edward Smith et al. · 2021 · JAMA
32. Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark
    Kasper Gadsbøll, Laila Stærk, Emil Loldrup Fosbøl, Caroline Sindet‐Pedersen, Anna Gundlund, Gregory Y.H. Lip, Gunnar Gislason, Jonas Bjerring Olesen · 2016 · European Heart Journal
33. Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants
    Victoria Allan, Sreeram V Ramagopalan, Jack Mardekian, Aaron K. Jenkins, Xiaoyan Li, Xianying Pan, Xuemei Luo · 2020 · Journal of Comparative Effectiveness Research
34. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation
    Laurent Fauchier, Olivier Villejoubert, Nicolas Clémenty, Anne Brunet Bernard, Bertrand Pierre, Denis Angoulvant, Fabrice Ivanés, Dominique Babuty, Gregory Y.H. Lip · 2016 · The American Journal of Medicine
35. Screening for atrial fibrillation: a call for evidence
    Nicholas Robert Jones, Clare J Taylor, Richard F. Hobbs, Louise J. Bowman, Barbara Casadei · 2019 · European Heart Journal
36. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial
    Diener, Hans-Christoph, Eikelboom, John, Connolly, Stuart J, Joyner, Campbell D, Hart, Robert G, Lip, Gregory YH, O'Donnell, Martin, Hohnloser, Stefan H, Hankey, Graeme J, Shestakovska, Olga et al. · 2012 · The Lancet Neurology
37. An Update on the Prognosis of Patients With Atrial Fibrillation
    David D. McManus, Michiel Rienstra, Emelia J. Benjamin · 2012 · Circulation
38. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)
    Charles Michael Gibson, Roxana Mehran, Christoph Bode, J. Halperin, Freek W.A. Verheugt, Peter Wildgoose, Martin van Eickels, Gregory Y.H. Lip, Marc C. Cohen, Steen Husted et al. · 2014 · American Heart Journal
39. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time
    Ziad Hijazi, Stefan Hans Hohnloser, Ulrika Andersson, John Hunter Alexander, Michael Hanna, Mátyás Keltai, Alexander N. Parkhomenko, Jose Luis Lopez-Sendon, Renato D. Lópes, Agneta Siegbahn et al. · 2016 · JAMA Cardiology
40. Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation
    Hart, Robert G., Pearce, Lesly A., Aguilar, Maria I. · 2007 · Annals of Internal Medicine
41. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC
    Anja Katholing, Christopher Wallenhorst, Saul Benedict Freedman, Carlos Martínez · 2015 · Thrombosis and Haemostasis
42. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study
    Yves Laurent Bayard, Heyder Omran, Petr Neužil, Leif Thuesen, Maximilian Pichler, Edward Rowland, Angelo Bruno Ramondo, Witold Rużyłło, Werner Budts, Gilles Montalescot et al. · 2010 · EuroIntervention
43. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
    Emily Claire O'Brien, DaJuanicia N. Holmes, Jack Ansell, Larry A. Allen, Elaine M. Hylek, Peter Russell Kowey, Bernard John Gersh, Gregg C. Fonarow, Christopher R. Koller, Michael D. Ezekowitz et al. · 2014 · American Heart Journal
44. Revised A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey
    Ron Pisters, Deirdre A. Lane, Robby Nieuwlaat, Hjgm Crijns, Gregory Y.H. Lip · 2012
45. Performance of handheld electrocardiogram devices to detect atrial fibrillation in a cardiology and geriatric ward setting
    Lien Desteghe, Zina Raymaekers, Mark Lutin, Johan M. Vijgen, Dagmara M. Dilling-Boer, Pieter Koopman, Joris Schurmans, Philippe Vanduynhoven, Paul Dendale, Hein Heidbüchel · 2016 · EP Europace
46. Age-Specific Incidence, Outcome, Cost, and Projected Future Burden of Atrial Fibrillation–Related Embolic Vascular Events
    Gabriel S.C. Yiin, Dominic P. J. Howard, Nicola L. M. Paul, Linxin Li, Ramón Luengo-Fernández, Linda M. Bull, Sarah J.V. Welch, Sergei A. Gutnikov, Ziyah Mehta, Peter Malcolm Rothwell · 2014 · Circulation
47. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
    Gregory Y.H. Lip, Marco Proietti, Tatjana Potpara, MOUSSA C. MANSOUR, Irina Savelieva, Hung‐Fat Tse, Andreas Goette, A. John Camm, Carina Blomström‐Lundqvist, Dhiraj Gupta et al. · 2023 · EP Europace
48. Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients
    Bob Weijs, Yuri Blaauw, Roger J. M. W. Rennenberg, Leon J. Schurgers, Carl C. Timmermans, Laurent Pison, Robby Nieuwlaat, Leonard Hofstra, Abraham A. Kroon, Joachim Ernst Wildberger et al. · 2011 · European Heart Journal
49. Design of Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate vs. Acetylsalicylic Acid in Patients with Embolic Stroke of Undetermined Source (Re-Spect Esus)
    Hans‐Christoph Diener, J. Donald Easton, Christopher Bull Granger, Lisa Cronin, Christine Duffy, Daniel Cotton, Martina Brueckmann, Ralph L. Sacco · 2015 · International Journal of Stroke
50. Pharmacogenetic‐guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon
    Talitha I. Verhoef, Ken Redekop, Ann K. Daly, Rianne MF van Schie, Anthonius de Boer, Anke H. Maitland‐van der Zee · 2013 · British Journal of Clinical Pharmacology
51. Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation
    Yi‐Hsin Chan, Chi-Tai Kuo, Yung‐Hsin Yeh, Shang‐Hung Chang, Lung‐Sheng Wu, Hsin‐Fu Lee, Hui‐Tzu Tu, Lai‐Chu See · 2016 · Journal of the American College of Cardiology
52. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
    Jonas Bjerring Olesen, Rikke Sørensen, Morten Lock Hansen, Morten Lamberts, Peter Ejvin Weeke, Anders Pretzmann Mikkelsen, Lars Køber, Gunnar Gislason, Christian Tobias Torp-Pedersen, Emil Loldrup Fosbøl · 2014 · EP Europace
53. Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies
    Apostolos Tzikas, David R. Holmes, Sameer A. Gafoor, Carlos Eduardo Ruiz, Carina Blomström‐Lundqvist, Hans‐Christoph Diener, Riccardo Cappato, Saibal Kar, Randal J. Lee, Robert A. Byrne et al. · 2016 · EuroIntervention
54. Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment
    John W. Eikelboom, Martin James O'Donnell, Salim Yusuf, Rafael Díaz, Greg C. Flaker, Robert G. Hart, Stefan Hans Hohnloser, Campbell D. Joyner, Jack Lawrence, Prem Pais et al. · 2010 · American Heart Journal
55. Thromboembolism in Atrial Fibrillation
    Jan Menke, Lars Lüthje, Andreas Kastrup, Jörg Larsen · 2010 · The American Journal of Cardiology
56. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia
    Victoria Jacobs, Scott C. Woller, Scott M. Stevens, Heidi Thomas May, Tami L. Bair, Jeffrey L. Anderson, Brian G. Crandall, John D. Day, Katie Johanning, Yenh Long et al. · 2014 · Heart Rhythm
57. Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
    Gregory Y.H. Lip, Kang-Ling Wang, Chern‐En Chiang · 2014 · International Journal of Cardiology
58. Stroke and Thromboembolism in Atrial Fibrillation
    Ron Pisters, Deirdre A. Lane, Francisco R. Marín, A. John Camm, Gregory Y.H. Lip · 2012 · Circulation Journal
59. Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice
    Xiaoyan Li, Steve Deitelzweig, Allison V. Keshishian, Melissa Hamilton, Ruslan V. Horblyuk, Kiran B. Gupta, Xuemei Luo, Jack Mardekian, Keith E. Friend, Anagha Nadkarni et al. · 2017 · Thrombosis and Haemostasis
60. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score
    Lip, Gregory Y.H., Skjøth, Flemming, Rasmussen, Lars Hvilsted, Larsen, Torben Bjerregaard · 2015 · Journal of the American College of Cardiology
61. Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
    Gregory Y.H. Lip · 2012 · European Heart Journal
62. Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries
    Harriette G.C. Van Spall, Lars C. Wallentin, Salim Yusuf, John W. Eikelboom, Robby Nieuwlaat, Sean Yang, Conrad Kabali, Paul A. Reilly, Michael D. Ezekowitz, Stuart J. Connolly · 2012 · Circulation
63. Implications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial Fibrillation
    Gregory Y.H. Lip · 2010 · The American Journal of Medicine
64. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
    John Hunter Alexander, Renato D. Lópes, Laine Elliott Thomas, Marco Alings, Dan Atar, Philip E. Aylward, Shinya Goto, M. Hanna, Kurt Huber, Steen Husted et al. · 2013 · European Heart Journal
65. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration
    Ryan T. Borne, Colin I. O’Donnell, Mintu P. Turakhia, Paul D. Varosy, Cynthia Anne Jackevicius, Lucas Marzec, Frederick A. Masoudi, Paul L. Hess, Thomas M. Maddox, P. Michael Ho · 2017 · BMC Cardiovascular Disorders
66. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording
    Aronsson, Mattias, Svennberg, Emma, Rosenqvist, Mårten, Engdahl, Johan, Al-Khalili, Faris, Friberg, Leif, Frykman-Kull, Viveka, Levin, Lars-Åke · 2015 · Europace
67. Percutaneous Left Atrial Appendage Closure
    Jacqueline Saw, Mathieu Lempereur · 2014 · JACC: Cardiovascular Interventions
68. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation
    Jack Ansell, Simon H Mantha · 2012 · Thrombosis and Haemostasis
69. Current Trial-Associated Outcomes With Warfarin in Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
    Rory Hachamovitch · 2012 · Archives of Internal Medicine
70. Atrial fibrillation burden: a new outcome predictor and therapeutic target
    Nina Becher, Andreas Metzner, Tobias Toennis, Paulus F. Kirchhof, Renate B. Schnabel · 2024 · European Heart Journal
71. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study
    J. Hippisley-Cox, C. Coupland, P. Brindle · 2013 · British medical journal
72. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    A. Schjerning Olsen, G. Gislason, P. McGettigan, E. Fosbøl, R. Sørensen, M. L. Hansen, L. Køber, C. Torp-Pedersen, M. Lamberts · 2015 · Journal of the American Medical Association (JAMA)
73. Racial Disparities in Awareness and Treatment of Atrial Fibrillation
    James Frederick Meschia, Peter Merrill, Elsayed Z. Soliman, Virginia J. Howard, Kevin M. Barrett, Neil A. Zakai, Dawn Kleindorfer, Monika M. Safford, George Howard · 2010 · Stroke
74. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
    Björck, Fredrik, Renlund, Henrik, Lip, Gregory Y. H., Wester, Per, Svensson, Peter J., Själander, Anders · 2016 · JAMA Cardiology
75. 2018 Korean Guideline of Atrial Fibrillation Management
    Boyoung Joung, Jung‐Myung Lee, Ki Hong Lee, Tae‐Hoon Kim, Eue‐Keun Choi, Woo‐Hyun Lim, Ki‐Woon Kang, Jae‐Sun Uhm, Hong Euy Lim, Junbeom Park et al. · 2018 · Korean Circulation Journal
76. Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
    Jan Beyer‐Westendorf, BIRGIT EHLKEN, Thomas Evers · 2016 · EP Europace
77. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry
    Lip, Gregory Y.H., Laroche, Cécile, Popescu, Mircea Iaochim, Rasmussen, Lars Hvilsted, Vitali-Serdoz, Laura, Dan, Gheorghe-Andrei, Kalarus, Zbigniew, Crijns, Harry J.G.M., Oliveira, Mario Martins, Tavazzi, Luigi et al. · 2015 · Europace
78. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
    Danielle Clarkesmith, Helen M. Pattison, Phyo Khaing, Deirdre A. Lane · 2017 · Cochrane Database of Systematic Reviews
79. Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
    Jorge A. Wong, David Conen, Isabelle C. Van Gelder, William F. McIntyre, Harry J.G.M. Crijns, Jia Wang, Michael Robert Gold, Stefan Hans Hohnloser, Chu‐Pak Lau, Alessandro Capucci et al. · 2018 · Journal of the American College of Cardiology
80. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial
    Roberto Galea, Federico DE MARCO, Nicolas F. Meneveau, Adel Aminian, Frédéric Anselme, Christoph Gräni, Adrian Thomas Huber, Emmanuel Teíger, Xavier Iriart, Flora Babongo Bosombo et al. · 2021 · Circulation
81. Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II
    Menno Volkert Huisman, Kenneth Jay Rothman, Miney Paquette, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Changsheng Ma, Kristina Zint, Amelie Elsaesser et al. · 2015 · The American Journal of Medicine
82. Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation
    Pilar Gallego, Vanessa Roldán, José Miguel Torregrosa Diaz, Josefa Gálvez, Mariano Valdés, Vicente Vicente, Francisco R. Marín, Gregory Y.H. Lip · 2012 · Circulation Arrhythmia and Electrophysiology
83. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
    Menno Volkert Huisman, Gregory Y.H. Lip, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Shang‐Hung Chang, Kenneth Jay Rothman, Christine Teutsch, Kristina Zint, Diana Ackermann et al. · 2013 · American Heart Journal
84. Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies
    Shahrzad Salmasi, Peter S Loewen, Rachel Tandun, Jason G. Andrade, Mary A. De Vera · 2020 · BMJ Open
85. Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
    Andreas Zirlik, Christoph Bode · 2016 · Journal of Thrombosis and Thrombolysis
86. Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO)
    Noé Brasier, Christina J. Raichle, Marcus Dörr, Adrian Becke, Vivien Nohturfft, Stefan Weber, Fabienne Bulacher, Lorena Salomon, Thierry Noah, Ralf Birkemeyer et al. · 2018 · EP Europace
87. The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?
    John W. Eikelboom, Ganesan Karthikeyan · 2010 · Thrombosis and Haemostasis
88. Safety and efficacy of well managed warfarin
    Vilhelm Sjögren, Bartosz Grzymala-Lubanski, Henrik Renlund, Leif Friberg, Gregory Y.H. Lip, Peter J Svensson, Anders Själander · 2015 · Thrombosis and Haemostasis
89. Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III.
    Richard Paul Whitlock, Jeff S. Healey, Jessica Vincent, Kate Brady, Kevin Teoh, Alistair George Royse, Pallav J. Shah, Yingqiang Guo, Marco Alings, Richard Folkeringa et al. · 2014 · Europe PMC (PubMed Central)
90. The use of anticoagulants in the management of atrial fibrillation among general practices in England
    Campbell Cowan, Richard Healicon, Ian Robson, W Robert Long, James Barrett, Matthew Fay, Keith Tyndall, Chris P Gale · 2013 · Heart
91. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
    Page, Richard L., Joglar, José A., Caldwell, Mary A., Calkins, Hugh, Conti, Jamie B., Deal, Barbara J., Estes, N.A. Mark, Field, Michael E., Goldberger, Zachary D., Hammill, Stephen C. et al. · 2016 · Circulation
92. Stroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation
    Gregory Y.H. Lip, Nicolas Clémenty, Lauriane Pericart, Amitava Banerjee, Laurent Fauchier · 2014 · Stroke
93. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
    Myung‐Jin Cha, Eue‐Keun Choi, Kyungdo Han, So‐Ryoung Lee, Woo‐Hyun Lim, Seil Oh, Gregory Y.H. Lip · 2017 · Stroke
94. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
    Miho Kimachi, Toshi A. Furukawa, Kimihiko Kimachi, Yoshihito Goto, Shingo Fukuma, Shunichi Fukuhara · 2017 · Cochrane Database of Systematic Reviews
95. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
    Chern‐En Chiang, Tsu-Juey Wu, Kwo-Chang Ueng, Tze‐Fan Chao, Kuan‐Cheng Chang, Chun-Chieh Wang, Yenn‐Jiang Lin, Wei‐Hsian Yin, Jen‐Yuan Kuo, Wei‐Shiang Lin et al. · 2016 · Journal of the Formosan Medical Association
96. Assessment of a Machine Learning Model Applied to Harmonized Electronic Health Record Data for the Prediction of Incident Atrial Fibrillation
    Premanand Tiwari, Kathryn L. Colborn, Derek E. Smith, Fuyong Xing, Debashis Ghosh, Michael A. Rosenberg · 2020 · JAMA Network Open
97. Mobile Phone–Based Use of the Photoplethysmography Technique to Detect Atrial Fibrillation in Primary Care: Diagnostic Accuracy Study of the FibriCheck App
    Tine Proesmans, Christophe Mortelmans, Ruth Van Haelst, Frederik Hendrik Verbrugge, Pieter M. Vandervoort, Bert Vaes · 2018 · JMIR mhealth and uhealth
98. CANADIAN BEST PRACTICE RECOMMENDATIONS FOR STROKE CARE
    M. Patrice Lindsay · 2013
99. Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke
    Jonathan Chong Hsu, Thomas M. Maddox, Kevin F. Kennedy, David F. Katz, Lucas Marzec, Steven A. Lubitz, Anil K. Gehi, Mintu P. Turakhia, Gregory M. Marcus · 2016 · Journal of the American College of Cardiology
100. Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation [RETIRED]
     Antonio Culebras, Steven Russell Messe, Seemant Chaturvedi, Carlos S. Kase, Gary Gronseth · 2014 · Neurology